American Society of Hematology Announces 2021 Scholar Award Recipients
(WASHINGTON, January 13, 2021) — The American Society of Hematology (ASH) today announced the 36 recipients of its 2021 Scholar Awards. One of ASH’s most prestigious research award programs, the ASH Scholar Awards financially support fellows and junior faculty dedicated to careers in hematology research as they transition from training programs to careers as independent investigators.
Each Scholar Award provides $100,000 for the Fellow level, $125,000 for the new Fellow to Faculty Scholars level, or $150,000 for the Junior Faculty level. The program funds hematologists in the United States and Canada who conduct basic, translational, and clinical research that furthers the understanding and treatment of blood disorders. ASH Scholar Awards are made possible through support from the ASH Foundation as well as from the corporate community, individual donors, and funds committed by the Society. ASH gratefully acknowledges this year’s corporate supporters: AstraZeneca, Bristol Myers Squibb, Janssen Biotech, Inc., Merck & Co., Inc., and Pharmacyclics LLC.
“When you’re beginning your research career, receiving funding from an organization like ASH not only provides the necessary support to pursue your goals but it also instills confidence that your work is worthwhile,” said 2021 ASH President Martin S. Tallman, MD, of Memorial Sloan Kettering Cancer Center. “The ASH Scholar Award has been a turning point in the careers of fellows and early career faculty who have gone on to become leaders in our field. We congratulate this year’s recipients and look forward to watching their promising research careers unfold.”
The 2021 Scholar Awards recipients are:
Basic/Translational Research Fellows
Casey Katerndahl, PhD
Washington University in St. Louis
Christine Zhang, PhD
Washington University School of Medicine
Diu Nguyen, DPhil
Memorial Sloan Kettering Cancer Center
Eugene Khandros, MD, PhD
The Children's Hospital of Philadelphia
Han Dong, PhD
Dana-Farber Cancer Institute
Kristen Schratz, MD
Johns Hopkins University School of Medicine
Marlise L. Guerrero Schimpf, PhD
University of Miami Miller School of Medicine
Moua Yang, PhD
Beth Israel Deaconess Medical Center
Scott Millman, MD, PhD
Memorial Sloan Kettering Cancer Center
Yimeng Gao, PhD
Yale University
Basic/Translational Fellow to Faculty
Aaron Viny, MD
Columbia University Irving Medical Center
Brooke Sadler, PhD
Washington University in St. Louis
Coraline Mlynarczyk, PhD
Weill Cornell Medicine
Courtney Jones, PhD
University Health Network
Elisa Ten Hacken, PhD
Dana-Farber Cancer Institute
Franco Izzo, PhD
Weill Cornell Medicine
Roger Belizaire, MD, PhD
Brigham and Women's Hospital
Samuel Ng, MD, PhD
Dana-Farber Cancer Institute
Basic/Translational Junior Faculty
Ansuman Satpathy, MD, PhD
Stanford University
Dang Nguyen, PhD
University of Minnesota
Jeevisha Bajaj, PhD
University of Rochester Medical Center
Koichi Takahashi, MD, PhD
The University of Texas MD Anderson Cancer Center
Lisa Roth, MD
Weill Cornell Medicine
Rui Lu, PhD
University of Alabama At Birmingham
Satheesh Chonat, MD
Emory University School of Medicine
Shannon Buckley, PhD
University of Nebraska Medical Center
Stanley Lee, PhD
Fred Hutchinson Cancer Research Center
Clinical Fellows
Ghadeer Dawwas, PhD
University of Pennsylvania
Julia Xu, MD
National Institutes of Health
Roni Shouval, MD, PhD
Memorial Sloan Kettering Cancer Center
Clinical Junior Faculty
Aimee Talleur, MD
St. Jude Children's Research Hospital
Ami Patel, MD
Huntsman Cancer Institute
Eboni Lance, MD, PhD
Hugo W. Moser Research Institute At Kennedy Krieger, Inc.
Oreofe Odejide, MD
Dana-Farber Cancer Institute
Richard Lin, MD, PhD
Memorial Sloan Kettering Cancer Center
Shruti Chaturvedi, MBBS
Johns Hopkins University School of Medicine
The American Society of Hematology (ASH) (www.hematology.org) is the world’s largest professional society of hematologists dedicated to furthering the understanding, diagnosis, treatment, and prevention of disorders affecting the blood. For more than 60 years, the Society has led the development of hematology as a discipline by promoting research, patient care, education, training, and advocacy in hematology. ASH publishes Blood (www.bloodjournal.org), the most cited peer-reviewed publication in the field, and Blood Advances (www.bloodadvances.org), an online, peer-reviewed open-access journal.
Contact
Amanda Szabo
American Society of Hematology
[email protected]
Help ASH Build an Inclusive Hematology Community!
ASH is committed to building and nurturing a global hematology community and workforce inclusive of diverse perspectives, talents, and experiences as it works toward one collective goal: helping hematologists conquer blood diseases worldwide.
How Can You Help?
Visit your My Account page, make needed updates to your demographic details, and select your preferred level of ASH access to your information; aggregated or individually identifiable, or choose not to provide or share your information. By sharing information about who you are, you will help ASH have a better appreciation of the diverse needs and talents present in the field, and help to build a more inclusive, collaborative hematology community. It will take only a few moments to complete!
Update Access to Demographic Information Learn About Our Mission